Career timeline

Mark’s career journey reflects a continuous progression of research, leadership, and innovation in genomics and healthcare. He began his professional path at a national biomedical research institute in the UK, serving as a Research Officer from 1984 to 1996. During this time, he joined a leading cancer research foundation in London, contributing to pioneering efforts in early genome mapping and cancer biology research.

In 1996, Mark transitioned to industry leadership at a global pharmaceutical company, which later merged into a larger multinational. Over nearly a decade, he directed transnational genetics teams across the UK and the USA, establishing a world-class genetic biobank of over 50,000 DNA samples and playing an important role in the FDA relabeling of Abacavir—a landmark in pharmacogenomics.

From 2005 to 2010, Mark moved into academic leadership as Director of a Center for Medical Genomics and a cancer institute’s Biomarker Service Center at a major U.S. research university. There, he expanded the university’s genomic capabilities, helped the cancer institute achieve the state’s first-ever NCI designation, and mentored medical fellows and graduate students while launching genomics education initiatives.

Mark’s entrepreneurial spirit led him to co-found an Inc. 500 genomics and biomarker company in 2010, where he served as Chief Scientific Officer until December 2019. Under his leadership, the genomics CRO managed contracts worth multimillion dollars, including projects with a national veterans’ genomic research program, and formed strategic partnerships with large healthcare providers, government agencies, and national research organizations. The company was recognized as an Inc. 500 Fastest Growing Company from 2015 to 2017, and Mark received multiple honors, including state-level industry awards.

Following the company’s acquisition, he was employed by a leading AI-driven healthcare technology firm, providing genomics and biomarker expertise. Mark co-founded a healthcare AI platform, dedicated to transforming physician workflows. His focus remains on enhancing clinical efficiency, improving patient experience, and driving next-generation healthcare innovation.